REGULATORY INTELLIGENCE·Warning Letter
RLC Labs' Thyroid USP Products Recalled Due to CGMP Deviations: Supply Chain and Regulatory Implications
RLC Labs Inc. initiated a Class II recall (D-1609-2020) for WP Thyroid and Westhroid Pure, 1 Grain (65 mg) Thyroid USP products, citing Current Good Manufacturing Practice (CGMP) deviations that led to subpotent conditions. This event, now terminated, underscores critical quality control vulnerabilities for procurement and regulatory teams managing essential hormone therapies, demanding robust supplier oversight.
90-Day Activity